“AI provides an additional prospective quality control, that we are looking at the right foci and identify the right areas of cancer. The ability of Ibex’s AI platform, not only to detect small foci of cancer that can be missed, but more interestingly and importantly higher-grade cancers that can be very small, make it a perfect companion for pathologists who are reviewing a lot of diagnostic material or may not have the expertise to analyze this material with that level of confidence.”
Mahul B. Amin, MD
Share this article:
Share this article:
Subscribe to our newsletter:
By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.
About IBEX
IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.
Subscribe to our newsletter:
By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.